Search research articles
Contact Us
Filters
Showing results (151-160 of 678) with videos related to
Page
of 68
Sort By:
Brain Research
|
November 9, 1981
CCK-containing terminals in the hippocampus are derived from intrinsic neurons: an immunohistochemical and radioimmunological study
G Handelmann, D K Meyer, M C Beinfeld, et al.
Expert Review of Pharmacoeconomics & Outcomes Research
|
June 10, 2010
Health-related quality of life and economic burden in patients with restless legs syndrome
Jens P Reese, Karin Stiasny-Kolster, Wolfgang H Oertel, et al.
Science (New York, N.Y.)
|
January 8, 1982
Origin of the cholecystokinin-containing fibers in the rat caudatoputamen
D K Meyer, M C Beinfeld, W H Oertel, et al.
Pharmacology, Biochemistry, and Behavior
|
February 23, 2000
The protective effects of PBN against MPTP toxicity are independent of hydroxyl radical trapping
B Ferger, P Teismann, C D Earl, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
October 2, 1998
Polysomnographic sleep measures in patients with uremic and idiopathic restless legs syndrome
T C Wetter, K Stiasny, R Kohnen, et al.
European Neurology
|
July 17, 2008
Real-life evaluations of compliance with mandatory drug safety monitoring exemplified with tolcapone in Parkinson's disease
Marcus M Unger, Jens P Reese, Wolfgang H Oertel, et al.
Neuroscience
|
January 1, 1981
Production of a specific antiserum to rat brain glutamic acid decarboxylase by injection of an antigen-antibody complex
W H Oertel, D E Schmechel, M L Tappaz, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
June 5, 1998
Treatment of restless leg syndrome with pergolide--an open clinical trial
J Winkelmann, T C Wetter, K Stiasny, et al.
Der Internist
|
December 31, 1997
[Long-term monitoring in neurological diseases]
K Stiasny, F Rosenow, A Hartmann, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
February 24, 2005
Long-term efficacy and safety of pramipexole in advanced Parkinson's disease: results from a European multicenter trial
J Carsten Möller, Wolfgang H Oertel, Jürgen Köster, et al.
Page
of 68
Search research articles
Search
Showing results (151-160 of 678) with videos related to
Sort By:
Page
of 68
Brain Research
|
November 9, 1981
CCK-containing terminals in the hippocampus are derived from intrinsic neurons: an immunohistochemical and radioimmunological study
G Handelmann, D K Meyer, M C Beinfeld, et al.
Expert Review of Pharmacoeconomics & Outcomes Research
|
June 10, 2010
Health-related quality of life and economic burden in patients with restless legs syndrome
Jens P Reese, Karin Stiasny-Kolster, Wolfgang H Oertel, et al.
Science (New York, N.Y.)
|
January 8, 1982
Origin of the cholecystokinin-containing fibers in the rat caudatoputamen
D K Meyer, M C Beinfeld, W H Oertel, et al.
Pharmacology, Biochemistry, and Behavior
|
February 23, 2000
The protective effects of PBN against MPTP toxicity are independent of hydroxyl radical trapping
B Ferger, P Teismann, C D Earl, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
October 2, 1998
Polysomnographic sleep measures in patients with uremic and idiopathic restless legs syndrome
T C Wetter, K Stiasny, R Kohnen, et al.
European Neurology
|
July 17, 2008
Real-life evaluations of compliance with mandatory drug safety monitoring exemplified with tolcapone in Parkinson's disease
Marcus M Unger, Jens P Reese, Wolfgang H Oertel, et al.
Neuroscience
|
January 1, 1981
Production of a specific antiserum to rat brain glutamic acid decarboxylase by injection of an antigen-antibody complex
W H Oertel, D E Schmechel, M L Tappaz, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
June 5, 1998
Treatment of restless leg syndrome with pergolide--an open clinical trial
J Winkelmann, T C Wetter, K Stiasny, et al.
Der Internist
|
December 31, 1997
[Long-term monitoring in neurological diseases]
K Stiasny, F Rosenow, A Hartmann, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
February 24, 2005
Long-term efficacy and safety of pramipexole in advanced Parkinson's disease: results from a European multicenter trial
J Carsten Möller, Wolfgang H Oertel, Jürgen Köster, et al.
Page
of 68